Published online Sep 14, 2025. doi: 10.3748/wjg.v31.i34.110611
Revised: July 3, 2025
Accepted: August 13, 2025
Published online: September 14, 2025
Processing time: 87 Days and 2.3 Hours
Perianal fistulising Crohn’s disease is a challenging complication that can affect up to 20% of patients with Crohn’s disease and is associated with significant morbidity. Despite advances in medical therapies, particularly anti-tumor necrosis factor agents, the majority of patients still require surgical intervention. Accurate diagnosis and monitoring are essential to optimise outcomes and guide multidi
Core Tip: Perianal fistulising Crohn’s disease affects up to 20% of patients and frequently requires combined medical and surgical management. Accurate and objective disease assessment is essential for the diagnosis, monitoring, and guidance of therapeutic interventions. Magnetic resonance imaging of the pelvis is the gold standard imaging modality for the evaluation of perianal fistulising Crohn’s disease. However, modalities such as endoanal ultrasound and transperineal ultrasound represent practical and accessible alternatives, particularly for repeated short to medium-term disease reassessment. This article aims to evaluate and compare the diagnostic accuracy and clinical utility of magnetic resonance imaging, endoanal ultrasound, and transperineal ultrasound in the assessment of perianal fistulising Crohn’s disease.